Berchuck A - Search Results

1

High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer.

Huang Z, Wen Y, Shandilya R, Marks JR, Berchuck A, Murphy SK. Huang Z, et al. Among authors: berchuck a. Nucleic Acids Res. 2006 Jan 23;34(2):555-63. doi: 10.1093/nar/gkj468. Print 2006. Nucleic Acids Res. 2006. PMID: 16432260 Free PMC article.

2

The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells.

Boente MP, Berchuck A, Rodriguez GC, Davidoff A, Whitaker R, Xu FJ, Marks J, Clarke-Pearson DL, Bast RC Jr. Boente MP, et al. Among authors: berchuck a. Am J Obstet Gynecol. 1992 Dec;167(6):1877-82. doi: 10.1016/0002-9378(92)91790-h. Am J Obstet Gynecol. 1992. PMID: 1361720

3

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: berchuck a. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

4

Overexpression and mutation of p53 in endometrial carcinoma.

Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR. Kohler MF, et al. Among authors: berchuck a. Cancer Res. 1992 Mar 15;52(6):1622-7. Cancer Res. 1992. PMID: 1540970

5

p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.

Kerns BJ, Jordan PA, Moore MB, Humphrey PA, Berchuck A, Kohler MF, Bast RC Jr, Iglehart JD, Marks JR. Kerns BJ, et al. Among authors: berchuck a. J Histochem Cytochem. 1992 Jul;40(7):1047-51. doi: 10.1177/40.7.1607637. J Histochem Cytochem. 1992. PMID: 1607637

6

Overexpression and mutation of p53 in epithelial ovarian cancer.

Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC Jr, Berchuck A. Marks JR, et al. Among authors: berchuck a. Cancer Res. 1991 Jun 1;51(11):2979-84. Cancer Res. 1991. PMID: 2032235

7

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC Jr, Iglehart JD, Marks JR. Elbendary A, et al. Among authors: berchuck a. Cell Growth Differ. 1994 Dec;5(12):1301-7. Cell Growth Differ. 1994. PMID: 7696178

8

Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.

Liu FS, Kohler MF, Marks JR, Bast RC Jr, Boyd J, Berchuck A. Liu FS, et al. Among authors: berchuck a. Obstet Gynecol. 1994 Jan;83(1):118-24. Obstet Gynecol. 1994. PMID: 8272291

9

The p53 tumor suppressor gene frequently is altered in gynecologic cancers.

Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J, Bast RC Jr. Berchuck A, et al. Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):246-52. doi: 10.1016/s0002-9378(94)70414-7. Am J Obstet Gynecol. 1994. PMID: 8296829 Review.

10

Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells.

Lidor YJ, Xu FJ, Martínez-Maza O, Olt GJ, Marks JR, Berchuck A, Ramakrishnan S, Berek JS, Bast RC Jr. Lidor YJ, et al. Among authors: berchuck a. Exp Cell Res. 1993 Aug;207(2):332-9. doi: 10.1006/excr.1993.1200. Exp Cell Res. 1993. PMID: 8344385

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters